Author: Fan, Linzi; Jiang, Shuang; Yang, Xinrong; Wang, Zhibin; Yang, Chunjuan
Title: COVID-19 Drug Treatment in China Cord-id: m5oq6ygu Document date: 2020_6_19
ID: m5oq6ygu
Snippet: PURPOSE OF REVIEW: An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19. RECENT FINDINGS: At present, the strategy of new use of old drugs is mainly used to screen candidate drugs against the novel coronavirus (later termed severe acute respiratory syndrom
Document: PURPOSE OF REVIEW: An unprecedented outbreak of the novel coronavirus in China (COVID-19) occurred in December 2019, and then engulfed the entire world, presenting a significant and urgent threat to global health. Many research institutes have been involved in the development of drugs and vaccines against COVID-19. RECENT FINDINGS: At present, the strategy of new use of old drugs is mainly used to screen candidate drugs against the novel coronavirus (later termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) and inhibit excessive immune response. Related research has made great progress. SUMMARY: In this review, we summarize the drugs used for COVID-19 treatment in China based on the emerging basic and clinical data. It is hoped that this review will be useful to provide guidance for the prevention, treatment, and control of COVID-19.
Search related documents:
Co phrase search for related documents- active metabolite and lopinavir ritonavir: 1
- active metabolite favipiravir and lopinavir ritonavir: 1
- active treatment and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active treatment and adjuvant therapy: 1, 2, 3, 4, 5
- active treatment and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
- acute sars cov respiratory syndrome coronavirus and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute sars cov respiratory syndrome coronavirus and lopinavir antiviral therapy ritonavir: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and lopinavir interferon: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir tablet: 1
- adjuvant therapy and lopinavir interferon: 1
- adjuvant therapy and lopinavir ritonavir: 1, 2
Co phrase search for related documents, hyperlinks ordered by date